Ameritas Investment Partners’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.8K | Hold |
6,570
| – | – | ﹤0.01% | 1940 |
|
|
2025
Q1 | $30K | Hold |
6,570
| – | – | ﹤0.01% | 2381 |
|
|
2024
Q4 | $37.1K | Hold |
6,570
| – | – | ﹤0.01% | 2361 |
|
|
2024
Q3 | $31.8K | Hold |
6,570
| – | – | ﹤0.01% | 2430 |
|
|
2024
Q2 | $32.1K | Hold |
6,570
| – | – | ﹤0.01% | 2381 |
|
|
2024
Q1 | $87.3K | Buy |
6,570
+1,530
| +30% | +$20.3K | ﹤0.01% | 1822 |
|
|
2023
Q4 | $70.3K | Hold |
5,040
| – | – | ﹤0.01% | 1960 |
|
|
2023
Q3 | $66.8K | Buy |
5,040
+851
| +20% | +$11.3K | ﹤0.01% | 1923 |
|
|
2023
Q2 | $78.5K | Buy |
4,189
+622
| +17% | +$11.7K | ﹤0.01% | 1755 |
|
|
2023
Q1 | $51.4K | Hold |
3,567
| – | – | ﹤0.01% | 1961 |
|
|
2022
Q4 | $80.6K | Hold |
3,567
| – | – | ﹤0.01% | 1743 |
|
|
2022
Q3 | $122K | Buy |
3,567
+740
| +26% | +$25.3K | 0.01% | 1360 |
|
|
2022
Q2 | $43K | Hold |
2,827
| – | – | ﹤0.01% | 2090 |
|
|
2022
Q1 | $65K | Buy |
2,827
+1,616
| +133% | +$37.2K | ﹤0.01% | 1909 |
|
|
2021
Q4 | $45K | Hold |
1,211
| – | – | ﹤0.01% | 2195 |
|
|
2021
Q3 | $57K | Buy |
+1,211
| New | +$57K | ﹤0.01% | 2072 |
|